Quantitative evaluation of MPTP-treated nonhuman parkinsonian primates in the HALLWAY task

被引:21
作者
Campos-Romo, Aurelio [1 ]
Ojeda-Flores, Rafael [1 ]
Moreno-Briseno, Pablo [1 ]
Fernandez-Ruiz, Juan [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Lab Neuropsicol, Mexico City 04510, DF, Mexico
关键词
Parkinsonian syndrome; Primate model; Motor behavioral assessment; MPTP; Levodopa; Quantitative evaluation; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-INDUCED PARKINSONISM; BEHAVIORAL RECOVERY; COMMON MARMOSET; VERVET MONKEY; DISEASE; MODEL; SYSTEM;
D O I
10.1016/j.jneumeth.2008.10.026
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a progressive neurodegenerative disorder. An experimental model of this disease is produced in nonhuman primates by the administration of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In this work, we put forward a new quantitative evaluation method that uses video recordings to measure the displacement, gate, gross and fine motor performance of freely moving subjects. Four Vervet monkeys (Cercopithecus aethiops) were trained in a behavioral observation hallway while being recorded with digital video cameras from four different angles. After MPTP intoxication the animals were tested without any drug and after 30 and 90 min of Levodopa/Carbidopa administration. Using a personal computer the following behaviors were measured and evaluated from the video recordings: displacement time across the hallway, reaching time towards rewards, ingestion time, number of attempts to obtain rewards, number of rewards obtained, and level of the highest shelf reached for rewards. Our results show that there was an overall behavioral deterioration after MPTP administration and an overall improvement after Levodopa/Carbidopa treatment. This demonstrates that the HALLWAY task is a sensitive and objective method that allows detailed behavioral evaluation of freely moving monkeys in the MPTP Parkinson's disease model. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 33 条
[21]   CHRONIC PARKINSONISM IN HUMANS DUE TO A PRODUCT OF MEPERIDINE-ANALOG SYNTHESIS [J].
LANGSTON, JW ;
BALLARD, P ;
TETRUD, JW ;
IRWIN, I .
SCIENCE, 1983, 219 (4587) :979-980
[22]  
LANGSTON JW, 1984, BRAIN RES, V292, P390
[23]   Mutant genes responsible for Parkinson's disease [J].
Le, W ;
Appel, SH .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (01) :79-84
[24]   Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen [J].
Luquin, MR ;
Montoro, RJ ;
Guillén, J ;
Saldise, L ;
Insausti, R ;
Del Río, J ;
López-Barneo, J .
NEURON, 1999, 22 (04) :743-750
[25]   CSF5-HIAA and nighttime activity in free-ranging primates [J].
Mehlman, PT ;
Westergaard, GC ;
Hoos, BJ ;
Sallee, FR ;
Marsh, S ;
Suomi, SJ ;
Linnoila, M ;
Higley, JD .
NEUROPSYCHOPHARMACOLOGY, 2000, 22 (02) :210-218
[26]   The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease [J].
Moussaoui, S ;
Obinu, MC ;
Daniel, N ;
Reibaud, M ;
Blanchard, V ;
Imperato, A .
EXPERIMENTAL NEUROLOGY, 2000, 166 (02) :235-245
[27]   Complete locomotor recovery following corticospinal tract lesions: measurement of ground reaction forces during overground locomotion in rats [J].
Muir, GD ;
Whishaw, IQ .
BEHAVIOURAL BRAIN RESEARCH, 1999, 103 (01) :45-53
[28]   Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes [J].
Muramatsu, SI ;
Fujimoto, KI ;
Ikeguchi, K ;
Shizuma, N ;
Kawasaki, K ;
Ono, F ;
Shen, Y ;
Wang, LJ ;
Mizukami, H ;
Kume, A ;
Matsumura, M ;
Nagatsu, I ;
Urano, F ;
Ichinose, H ;
Nagatsu, T ;
Terao, K ;
Nakano, I ;
Ozawa, K .
HUMAN GENE THERAPY, 2002, 13 (03) :345-354
[29]   The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety [J].
Przedborski, S ;
Jackson-Lewis, V ;
Naini, AB ;
Jakowec, M ;
Petzinger, G ;
Miller, R ;
Akram, M .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (05) :1265-1274
[30]  
ROBINSON EL, 1993, AM J PHYSIOL, V265, P781